Role of drugs and devices in patients at risk of sudden cardiac death.
about
Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.Cost-effectiveness of implantable cardioverter-defibrillator in today's world.Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad LatinoamExtending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies.
P2860
Role of drugs and devices in patients at risk of sudden cardiac death.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of drugs and devices in patients at risk of sudden cardiac death.
@en
Role of drugs and devices in patients at risk of sudden cardiac death.
@nl
type
label
Role of drugs and devices in patients at risk of sudden cardiac death.
@en
Role of drugs and devices in patients at risk of sudden cardiac death.
@nl
prefLabel
Role of drugs and devices in patients at risk of sudden cardiac death.
@en
Role of drugs and devices in patients at risk of sudden cardiac death.
@nl
P2093
P2860
P50
P1476
Role of drugs and devices in patients at risk of sudden cardiac death
@en
P2093
Angelo Branzi
Cristian Martignani
Matteo Ziacchi
Mauro Biffi
Valentina Mantovani
P2860
P304
P356
10.1111/J.1472-8206.2010.00853.X
P577
2010-10-01T00:00:00Z